RecruitingNot ApplicableNCT07708571

Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management

A Randomized Controlled Study Evaluating the Effectiveness of Typology-based Coaching on Therapy Management for Patients With HRpos/HER2neg Early Breast Cancer Under Adjuvant Treatment With Ribociclib


Sponsor

Institut fuer Frauengesundheit

Enrollment

548 participants

Start Date

Nov 4, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate the effect of patient education and patient typology-based coaching on therapy persistence in breast cancer patients taking ribociclib. Researchers will compare the time to permanent treatment discontinuation of patients receiving personalized coaching to the time to permanent treatment discontinuation of patients who only receive standard of care education and counselling, to see if adherence to treatment can be improved by personalized patient coaching.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Typology-based coaching for people with hr+/her2- early breast cancer. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTypology-based coaching

Standardized patient coaching based on the Multinational Association of Supportive Care in Cancer (MASCC) Oral Agent Teaching Tool© (MOATT)


Locations(3)

Department of Gynecology and Obstetrics, Universitätsklinikum Augsburg

Augsburg, Bavaria, Germany

Department of Obstetrics and Gynecology, Uniklinikum Erlangen

Erlangen, Bavaria, Germany

MVZ Klinikum Aschaffenburg, Zweigstelle Hänatologie und Onkologie

Hösbach, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07708571


Related Trials